Retension Pharmaceuticals, Inc. SEC filings RTSN

Retension Pharmaceuticals, Inc. has 45 filings in SEC EDGAR's recent list, going back to Dec 5, 2023. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (officer or director change). The company's fiscal year ends on December 31.

Retension Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 23, 2026 Oct 21, 2026
S-8 Employee stock plan registration Oct 13, 2026 —
8-K Current report
Bylaw or fiscal year change
Oct 13, 2026 Oct 9, 2026
424B4 Prospectus Oct 9, 2026 —
EFFECT Filing Oct 8, 2026 —
S-1MEF Registration statement Oct 8, 2026 —
CERT Filing Oct 8, 2026 —
8-A12B For registration of certain classes Oct 8, 2026 —
S-1/A Amended registration statement Oct 7, 2026 —
S-1/A Amended registration statement Oct 5, 2026 —
S-1 Registration statement Sep 18, 2026 —
DRS/A Filing Aug 14, 2026 —
DRS/A Filing Jun 16, 2026 —
DRS/A Filing May 1, 2026 —
DRS Filing Feb 17, 2026 —
D Filing May 6, 2025 —
D/A Filing May 15, 2024 —
D Filing Dec 5, 2023 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RTSN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Mclean, VA
SEC filer status
, Emerging growth company
SEC CIK
2002988

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.